LTUS (Lotus Pharmaceuticals) up 10% on near record volume and no news.
People finding out how undervalued LTUS is: 97% revenue growth and 120% income growth 2005-2006, and on track for more of the same in 2007. Already booked .13/share for first 3q of 2007/on track to make .18/share.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.